Folate metabolism and development of Neural Tube Defects
Folate metabolism and development of Neural Tube Defects
批准号:
MR/J003794/1
负责人:
Nicholas Greene
金额:
$78.24万
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2012
资助国家:
英国
项目状态:
已结题
起止时间:
2012 至 --
中文摘要
在怀孕早期,胚胎发育中的一个关键事件是形成一种叫做神经管的结构,这种结构后来会发育成大脑和脊髓。神经管不能正确形成导致一组称为神经管缺陷的出生缺陷,其中胎儿的大脑和/或脊髓受到不可逆转的损伤,导致出生前或出后不久死亡,或存活的婴儿长期残疾。脊柱裂是最著名的NTD类型。总的来说,被忽视的热带病发生率约为千分之一,尽管这一比率有所不同,在某些区域(如北爱尔兰和苏格兰)要高得多。在世界范围内,每年大约发生13万例病例。被忽视热带病的风险取决于遗传因素和非遗传因素,如饮食,但确切的原因尚不清楚。然而,如果母亲在怀孕前和怀孕早期服用叶酸补充剂,受影响怀孕的风险可以大大降低。不幸的是,并非所有被忽视热带病都可以通过叶酸预防,因此需要额外的治疗。为了在预防所有被忽视热带病方面取得进一步进展,我们需要更好地了解其原因。目前,大多数患者无法解释NTD的遗传原因,但在揭示这些疾病的复杂性方面正在取得相当大的进展。我们的长期目标是确定可单独或联合使用的被忽视热带病的预防性治疗方法。在已经确定遗传风险因素的家庭中,这也意味着可以提供针对家庭的治疗。在所有细胞中,有效处理被称为叶酸的小分子(与叶酸有关)是许多不同功能所必需的,包括制造细胞分裂所需的DNA。一个重要的问题是,一些ntd是否由发育中的婴儿细胞处理叶酸的方式先天异常引起。我们最近研究了一组与叶酸处理有关的蛋白质,发现一些ntd患者在这些蛋白质中存在缺陷,而未受影响的人则没有。这一发现表明,这些问题可能直接导致被忽视热带病。支持这一观点的是,在同一组蛋白质中有缺陷的小鼠胚胎也会发展为ntd。这些小鼠模型为研究这些叶酸处理蛋白在胚胎中的作用以及如何预防相关的NTDs提供了机会。
英文摘要
During early pregnancy, a crucial event in the developing embryo is the formation of a structure called the neural tube, which will later develop into the brain and spinal cord. Failure of the neural tube to form correctly leads to a group of birth defects called neural tube defects (NTDs), in which the brain and/or spinal cord of the fetus become irreversibly damaged, resulting in death before or shortly after birth, or long term disability in surviving babies. Spina bifida is the best known type of NTD. Overall, NTDs occur in around 1 per 1,000 pregnancies although the rate varies and is significantly higher in some regions (e.g. Northern Ireland and Scotland). Worldwide, approximately 130,000 cases occur every year.The risk of NTDs depends on both inherited genetic factors and non-genetic factors such as diet, but the exact causes are not well understood. However, the risk of an affected pregnancy can be substantially reduced if the mother takes folic acid supplements before and during early pregnancy. Unfortunately, not all cases of NTDs are preventable by folic acid, so additional therapies are needed. In order to make further progress towards prevention of all NTDs we need a better understanding of their causes. At the present time the genetic cause of an NTD cannot be explained in most patients, but considerable progress is being made towards unravelling the complexity of these diseases. Our long-term goal is to identify preventive therapies for NTDs which may be used individually or in combination. In families where genetic risk factors have been identified this also means that family-specific therapies may be offered.In all cells, efficient handling of small molecules called folates, which are related to folic acid, is needed for a number of different functions including making DNA for cells to divide. An important question is whether some NTDs are caused by an inborn abnormality in the way that the cells in the developing baby handle folate. We recently studied a group of proteins that are involved in folate handling and found that some patients with NTDs have defects in these proteins, whereas unaffected people did not. This finding suggests that problems with these problems may directly cause NTDs. In support of this idea, mouse embryos that have defects in the same group of proteins also develop NTDs. These mouse models provide an opportunity to study what job these folate handling proteins are doing in the embryo and how the associated NTDs may be prevented.
期刊论文(10)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1002/wdev.71
发表时间:
2013-03
期刊:
WILEY INTERDISCIPLINARY REVIEWS-DEVELOPMENTAL BIOLOGY
影响因子:
--
作者:
[Copp, Andrew J., Greene, Nicholas D. E.]
通讯作者:
Greene, Nicholas D. E.
DOI:
10.1016/s1474-4422(13)70110-8
发表时间:
2013-08
期刊:
The Lancet. Neurology
影响因子:
--
作者:
[Copp AJ, Stanier P, Greene ND]
通讯作者:
Greene ND
DOI:
10.3945/ajcn.114.086603
发表时间:
2015-03
期刊:
The American journal of clinical nutrition
影响因子:
--
作者:
[Christensen KE, Mikael LG, Leung KY, Lévesque N, Deng L, Wu Q, Malysheva OV, Best A, Caudill MA, Greene ND, Rozen R]
通讯作者:
Rozen R
DOI:
10.1002/pd.5004
发表时间:
2017-03
期刊:
Prenatal diagnosis
影响因子:
3
作者:
[Autuori MC, Pai YJ, Stuckey DJ, Savery D, Marconi AM, Massa V, Lythgoe MF, Copp AJ, David AL, Greene ND]
通讯作者:
Greene ND
DOI:
10.1002/bdra.23533
发表时间:
2017-01-30
期刊:
Birth defects research
影响因子:
2.1
作者:
[Greene ND, Leung KY, Copp AJ]
通讯作者:
Copp AJ
共 8 条
The Glycine Cleavage System in Brain Development, Function and Disease
-
批准号:MR/W00500X/1
-
项目类别:Research Grant
-
资助金额:$299.24万
-
财政年份:2022
-
负责人:Nicholas Greene
-
依托单位:
Prevention of Neural Tube Defects by Inositol and Vitamin B12 (PONTib) - Development Trial
-
批准号:MR/T003847/1
-
项目类别:Research Grant
-
资助金额:$38.56万
-
财政年份:2021
-
负责人:Nicholas Greene
-
依托单位:
Bilateral BBSRC-SFI: Deciphering the function of the human Dihydrofolate reductase 2 gene
-
批准号:BB/P018084/1
-
项目类别:Research Grant
-
资助金额:$59.01万
-
财政年份:2017
-
负责人:Nicholas Greene
-
依托单位:
Understanding the role of the Glycine Cleavage System in Neural Tube Defects
-
批准号:MR/N003713/1
-
项目类别:Research Grant
-
资助金额:$109.42万
-
财政年份:2016
-
负责人:Nicholas Greene
-
依托单位:
Grainyhead-like genes and mammalian neural tube defects
-
批准号:G0802163/1
-
项目类别:Research Grant
-
资助金额:$80.26万
-
财政年份:2010
-
负责人:Nicholas Greene
-
依托单位:
Inositol-preventable neural tube defects: understanding the molecular causes and mechanisms of prevention
-
批准号:G0601546/1
-
项目类别:Research Grant
-
资助金额:$76.94万
-
财政年份:2007
-
负责人:Nicholas Greene
-
依托单位:
国内基金
海外基金
登录
查看更多内容
一碳代谢(One carbon metabolism)介导上调的 PD1/PDL1 驱动
肿瘤免疫逃逸
-
批准号:2024JJ9491
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:彭罗根
-
依托单位:
生物钟核受体Rev-erbα在缺血性卒中神经元能量代谢中的改善作用及机制研究
-
批准号:82371332
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:胡琴
-
依托单位:
Idh3a作为线粒体代谢—表观遗传检查点调控产热脂肪功能的机制研究
-
批准号:82370851
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:包玉倩
-
依托单位:
NPM1表观重塑巨噬细胞代谢及修复表型在心肌缺血损伤中的调控作用
-
批准号:82371825
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:占贞贞
-
依托单位:
海马神经元胆固醇代谢重编程致染色质组蛋白乙酰化水平降低介导老年小鼠术后认知功能障碍
-
批准号:82371192
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:田婕
-
依托单位:
“肠—肝轴”PPARα/CYP8B1胆汁酸合成信号通路在减重手术改善糖脂代谢中的作用与机制
-
批准号:82370902
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:田景琰
-
依托单位:
转运蛋白RCP调控巨噬细胞脂肪酸氧化参与系统性红斑狼疮发病的机制研究
-
批准号:82371798
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:叶俊娜
-
依托单位:
DACH1对糖尿病肾病足细胞脂质代谢的调控作用和机制研究
-
批准号:82370719
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:曹爱丽
-
依托单位:
Grem2通过BMPR-Smad1/5/8-PGC1α通路调控线粒体能量代谢在糖尿病肾病足细胞损伤中的机制研究
-
批准号:82370819
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:徐瑜
-
依托单位:
雄性线虫特异分泌蛋白F56D2.8调节衰老与寿命的机制研究
-
批准号:32100604
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:龚健科
-
依托单位: